KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Pacific Biosciences Of California (PACB) Assets Average (2016 - 2025)

Pacific Biosciences Of California has reported Assets Average over the past 15 years, most recently at $793.6 million for Q4 2025.

  • Quarterly results put Assets Average at $793.6 million for Q4 2025, down 41.44% from a year ago — trailing twelve months through Dec 2025 was $793.6 million (down 41.44% YoY), and the annual figure for FY2025 was $1.0 billion, down 32.0%.
  • Assets Average for Q4 2025 was $793.6 million at Pacific Biosciences Of California, down from $814.3 million in the prior quarter.
  • Over the last five years, Assets Average for PACB hit a ceiling of $2.0 billion in Q1 2022 and a floor of $793.6 million in Q4 2025.
  • Median Assets Average over the past 5 years was $1.6 billion (2024), compared with a mean of $1.5 billion.
  • Biggest five-year swings in Assets Average: soared 457.23% in 2021 and later plummeted 46.96% in 2025.
  • Pacific Biosciences Of California's Assets Average stood at $1.2 billion in 2021, then soared by 43.52% to $1.8 billion in 2022, then rose by 1.63% to $1.8 billion in 2023, then decreased by 25.62% to $1.4 billion in 2024, then crashed by 41.44% to $793.6 million in 2025.
  • The last three reported values for Assets Average were $793.6 million (Q4 2025), $814.3 million (Q3 2025), and $843.1 million (Q2 2025) per Business Quant data.